Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy requires careful dose titration over 16 to 20 weeks, with most patients reaching their therapeutic range between 1.0 and 2.4 milligrams weekly. Rather than chasing a predetermined 'full dose,' the goal is finding the lowest effective dose that produces weight loss while minimizing side effects. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies across all 50 states, with flat monthly pricing regardless of your current dose level.
How Semaglutide Dosing Works in Clinical Practice
Semaglutide treatment begins at 0.25 milligrams once weekly and increases gradually. After four weeks, the dose typically moves to 0.5 milligrams weekly. The subsequent four-week interval usually brings an increase to 1.0 milligrams, followed by another four-week wait before advancing to 1.7 milligrams. Some individuals continue to 2.4 milligrams, though this represents the highest approved dose in most clinical settings. This slow escalation allows your body to adapt while your healthcare provider monitors your response.
The titration schedule protects against gastrointestinal side effects that can occur with rapid dose increases. Clinical trials demonstrate that most patients experience meaningful weight loss at doses between 1.0 and 2.4 milligrams weekly. Your ideal dose depends on your unique metabolic profile, not on reaching a marketing-defined 'full dose.' PlexusDx supports dose adjustments through ongoing telemedicine consultations without charging more as your therapy evolves.
Understanding Dose Versus Therapeutic Response
A higher dose does not guarantee better weight loss for every person. Some individuals achieve excellent results at 1.0 or 1.7 milligrams, while others require 2.4 milligrams to reach their goals. Your genetic makeup, body composition, insulin sensitivity, and previous weight loss attempts all influence how your system responds to semaglutide. Precision-medicine approaches recognize that one-size-fits-all dosing ignores the biological reality of human variation.
PlexusDx Precision Peptide Genetic Test examines key peptide-pathway variants—including GLP1R rs6923761 and MC4R rs17782313—that influence your individual semaglutide response. Understanding these genetic insights helps your provider make informed decisions about your starting dose, expected timeline, and dose-escalation strategy. This personalized approach reduces the risk of unnecessary side effects and optimizes your chances of sustained weight loss.
Navigating Side Effects During Dose Escalation
Nausea, vomiting, constipation, and loss of appetite are common during the first four weeks at each new dose level. These effects typically diminish within days to two weeks as your digestive system acclimates. Staying hydrated, eating small frequent meals, and maintaining adequate fiber intake help many patients tolerate dose increases more comfortably. Some individuals benefit from temporary dose stabilization or a slower escalation schedule.
If side effects become severe or intolerable, your PlexusDx provider can pause the titration, reduce the dose, or switch to a different GLP-1 formulation. Oral semaglutide, for example, produces different absorption kinetics and may cause fewer gastrointestinal complaints for some patients. The goal is sustainable therapy that fits your lifestyle—not pushing through discomfort to reach an arbitrary dose number.
PlexusDx Semaglutide: Transparent Pricing and Access
PlexusDx compounded semaglutide injection starts at $149 per month, with no flat per-compound pricing increases and no insurance requirements. Your dose may need to go up, but your price won't. This flat-rate model eliminates the financial surprise many patients face when advancing to higher doses. HSA and FSA accounts can be used to offset costs, making semaglutide therapy more accessible.
All PlexusDx medications come from licensed 503A compounding pharmacies and are shipped directly to your home in all 50 states. Telemedicine consultations connect you with licensed providers who adjust your dose based on your progress, not on a rigid protocol. If you want deeper genetic insights into your weight loss pathways, the Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical 'full dose' of semaglutide used for weight loss?
Most patients use between 1.0 and 2.4 milligrams weekly. The highest FDA-approved maintenance dose is 2.4 milligrams, but many individuals achieve excellent weight loss at lower doses. The right dose for you depends on your individual response, not on reaching a preset maximum.
How long does it take to reach the full dose of semaglutide?
Dose escalation typically takes 16 to 20 weeks, increasing by 0.25 milligrams every four weeks. Some patients pause or slow the escalation to manage side effects. Your PlexusDx provider can adjust the timeline to match your comfort level and treatment goals.
Will PlexusDx charge me more if my semaglutide dose increases?
No. PlexusDx compounded semaglutide injection starts at $149 per month regardless of your current dose. As your therapy progresses and your dose adjusts upward, your monthly cost remains flat—a transparent pricing model designed to support long-term adherence.
What happens if I cannot tolerate the standard semaglutide dose escalation?
Your PlexusDx provider can slow the escalation, extend the interval between dose increases, or switch to oral semaglutide ($249/month). Side effects typically improve within 1-2 weeks at each new dose as your system adapts. If GLP-1 therapy causes persistent problems, your provider may recommend a different approach.
How does the PlexusDx Precision Peptide Genetic Test help with semaglutide dosing?
The genetic test examines 150+ insights across 14 metabolic pathways, including GLP1R rs6923761 and MC4R rs17782313, to predict how your body processes semaglutide and responds to weight loss therapy. These insights help your provider personalize your starting dose, titration speed, and medication choice for better outcomes and fewer side effects.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Ozempic Isn’t Working: Navigating Your Weight Loss Journey
Optimizing Your Zepbound Schedule: Choosing Your Best Injection Day for Sustainable Weight Loss